Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses

Medicine and Dentistry

• COVID-19 100%
• Meta-Analysis 100%
• Remdesivir 100%
• Infusion 12%
• Hydroxychloroquine 12%
• Lopinavir 12%
• Interferon 12%
• Disease Severity 6%
• Mortality Rate 6%
• Hospital Inpatient 6%
• Lung Ventilation 6%
• Kaplan Meier Method 6%
• Hospital Mortality 6%
• Placebo 6%
• Patient Characteristics 6%
• Physician 6%
• Antiviral Drug 6%
• Contraindication 6%

Pharmacology, Toxicology and Pharmaceutical Science

• Remdesivir 100%
• Lopinavir 12%
• Hydroxychloroquine 12%
• Interferon 12%
• Placebo 6%
• Mortality Rate 6%
• Disease Severity 6%
• Hospital Mortality 6%
• Antiviral Drug 6%